Book Value Bawat Bahagi: Alterity Therapeutics (ATHE)

Alterity Therapeutics Limited (ATHE) - korporatibong logo

Layunin ng Alterity Therapeutics (ATHE) na pigilan ang cellular senescence sa pamamagitan ng makabagong metal binding sa utak. Ang diversipikasyon ng small molecule pipeline ay nagbabawas ng mga regulatory risk, at ang proteksyon ng patent ay ganap na maitatatag pagkatapos ng mga huling pagsusuri. Ang book value per share ay nagpapakita ng capital dynamics, kung saan ang 1.62 ay sumasalamin sa pinakabagong metric value, na nagpapatunay sa kasalukuyang katatagang pinansyal ng pre-commercial business.

Stockholders Equity Bawat Bahagi Alterity Therapeutics Ltd (ATHE): para sa panahong 04.07.2022 - 28.10.2026

Alterity Therapeutics Ltd. - mga analytical breakdown at pangunahing sukatan (ATHE)

- presyo at pagtataya ng pinagkasunduang presyo:
Presyo ng Stock Alterity Therapeutics Ltd|ATHE - Konsensus ng Makatarungang Halaga
- datos sa market capitalization:
Kapitalisasyon sa Merkado Alterity Therapeutics Limited|ATHE - Kabuuang Halaga ng Negosyo
- datos sa book capitalization:
Netong Asset Bawat Isang Bahagi Alterity Therapeutics|ATHE - Accounting Capitalization|Ratio ng Market Capitalization sa Book Value alteritytherapeutics.com|ATHE - Mga Asset ng Kumpanya
- datos sa utang at liquidity:
Ratio ng Kabuuang Utang sa Stockholders Equity Alterity Therapeutics|ATHE - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Alterity Therapeutics Ltd|ATHE - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Alterity Therapeutics Limited
Fundamental valuation ng kumpanya:alteritytherapeutics.com, ATHE
Mga produktong ginagawa ng Alterity Therapeutics Ltd

Ang book value per share ay kumakatawan sa pagkakaiba sa pagitan ng lahat ng asset at liability ng issuer na hinati sa bilang ng mga security, na siyang nagtatakda ng aktwal na halaga ng stake ng may-ari. Ang pagsusuri ng equity per share ay kritikal na mahalaga para sa Alterity Therapeutics (ATHE), dahil ang kawalan ng kita at ang mga panganib ng pagkabigo ng trial ay ginagawang tanging sukatan ng katatagang pinansyal ang indicator na ito sa harap ng potensyal na pagkalugi.

Mga kakumpitensya ng Alterity Therapeutics (ATHE)

Book Value Bawat Bahagi Biogen Corp (BIIB)|NBIX - Accounting Value ng Bahagi|Book Value Bawat Bahagi RGC|AXSM (axsome.com) - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi ACADIA Pharmaceuticals Inc. (ACAD)|Stockholders Equity Bawat Bahagi Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Supernus Corp SUPN|Accounting Book Value Bawat Bahagi CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi AMLX|Trevi Corp (TRVI) - Net Asset Value Bawat Bahagi|PRAX (Praxis Precision Medicines) - Book Value Bawat Bahagi|Book Value Bawat Bahagi AVXL|Netong Asset Bawat Isang Bahagi CeriBell (CBLL)|Netong Asset Bawat Isang Bahagi Prothena Corporation PRTA|Accounting Book Value Bawat Bahagi Alector (ALEC)|Book Price ng Bahagi Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value Bawat Bahagi|NGNE: Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi AC Immune SA ACIU|Voyager Therapeutics Inc (VYGR) - Accounting Value ng Bahagi|NMRA: Book Value Bawat Bahagi|Net Assets Bawat Bahagi Scilex Holding Company, Inc. (SCLX)|Accounting Book Value Bawat Bahagi Tevogen Bio Holdings|Book Price ng Bahagi alphacognition.com ACOG|CGTX: Accounting Book Value Bawat Bahagi|IKT - Net Asset Value Bawat Bahagi|Accounting Book Value Bawat Bahagi Cassava (SAVA)|Assertio Holdings, Inc. (ASRT) - Accounting Value ng Bahagi|COYA - Accounting Book Value Bawat Bahagi|Vistagen (VTGN) - Book Price ng Bahagi|OVID - Book Value Bawat Bahagi|Accounting Value ng Bahagi Acumen Pharmaceuticals Inc.|CervoMed Inc - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi CLNN (clene.com)|Netong Asset Bawat Isang Bahagi PepGen|Accounting Value ng Bahagi Jupiter Neurosciences, Inc. JUNS|Relmada Therapeutics, Inc. - Book Value Bawat Bahagi|ANVS: Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi gracetx.com (GRCE)|Firefly Neuro (AIFF) - Book Value ng Bahagi|Book Value Bawat Bahagi KLTO (ANEW Medical)|Net Asset Value Bawat Bahagi NeuroSense Therapeutics, Ltd. (NRSN)|Accounting Book Value Bawat Bahagi RVPH|Book Value Bawat Bahagi metaviatx.com MTVA|Accounting Book Value Bawat Bahagi NeurAxis, Inc (NRXS)|Book Price ng Bahagi Helius Medical Technologies, Inc. HSDT|Book Value Bawat Bahagi PASG (Passage Bio Corp)|NEUP - Net Assets Bawat Bahagi|NERV (Minerva Neurosciences, Inc.) - Book Value Bawat Bahagi|ATHA (Athira Pharma Inc) - Accounting Book Value Bawat Bahagi|ADXN: Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi Alzamend|Book Value Bawat Bahagi CYCN|Book Value Bawat Bahagi protagenic.com PTIX|Accounting Book Value Bawat Bahagi Pasithea Therapeutics Corp. (KTTA)|Book Price ng Bahagi Cortigent Inc CRGT|Book Value Bawat Bahagi Avenue Therapeutics, Inc (ATXI)|BCLI - Accounting Value ng Bahagi|Book Value Bawat Bahagi CARA|CHRO (chromocell.com) - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Eliem Therapeutics, Inc. (ELYM)|Stockholders Equity Bawat Bahagi Intra-Cellular|Longboard Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Marinus Pharma MRNS|Accounting Book Value Bawat Bahagi NKGN (NKGen Biotech, Inc.)|neurobopharma.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Sage Therapeutics (SAGE)|SNPX: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi TRVN|Vigil Neuroscience, Inc. (VIGL) - Net Asset Value Bawat Bahagi|WENA (Anew Medical) - Book Value Bawat Bahagi|Book Value Bawat Bahagi CERE